Crossmark

Thapsigargin, Inhibitor of Sarco-Endoplasmic Ca2+-ATPase, Effectively Suppresses the Expression of S100A4 Protein in Human Breast Cancer Cell Line

Published Online: 2019-07-31

Published Print: 2019-05

Authors

Kotnova, A. P.

Lyanova, B. M.

Dukhanina, E. A.

Portseva, T. N.

Ilyin, Yu. V.

Georgieva, S. G.

Stepchenko, A. G.

Pankratova, E. V.
License Information

Text and Data Mining valid from 2019-05-01

Version of Record valid from 2019-05-01
More Information

Article History

Received: 28 December 2018

First Online: 31 July 2019

COMPLIANCE WITH ETHICAL STANDARDS

: The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Document is current